Komori
Dividends4512WAKAMOTO PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Concerning Revision of Dividend Forecast

The year-end dividend forecast for the fiscal year ending March 2025 was set at ¥3 per share, replacing the previous forecast of undecided. The annual dividend forecast is also ¥3 per share, equal to the actual dividend for the previous fiscal year.

Worth reading
64In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
3
¥ per share
Wording
Conditional
How definitive the wording is.

Dividend per share

Fiscal year ending March 2025
3YenDividend per share for this transactionPrior-year result ¥3, change ¥0
Previous-period resultsCurrent

Each vertical step represents one dividend payment, and the total height of the accumulated steps represents the annual dividend for the period. For periods showing only the annual amount, the payment breakdown is not provided, so only the end point is plotted.

Whether Submission to the General Meeting of Shareholders Is RequiredScheduled to be submitted to the General Meeting of Shareholders
Payout ratioFigures At least 50% / Category Policy basisThe percentage of earnings paid out as dividends.
Dividend policy

安定的な配当の実施並びに配当性向50%以上を基本としながら財務体質の強化を図りつつ製造設備・技術の強化、研究開発、営業活動の強化のための投資に積極的に資金を充当し、企業価値の増大を目指す。

Dividend per share
ItemDetails
Dividend per shareNot disclosed → 3.00 yen
Total Annual DividendsNot disclosed → 3.00 yen
Previous-period results (per share)Interim 0.00 yen / End of period 3.00 yen / Annual 3.00 yen
Payout ratioFigures At least 50% / Category Policy basis
Dividend policy安定的な配当の実施並びに配当性向50%以上を基本としながら財務体質の強化を図りつつ製造設備・技術の強化、研究開発、営業活動の強化のための投資に積極的に資金を充当し、企業価値の増大を目指す。
Whether Submission to the General Meeting of Shareholders Is RequiredScheduled to be submitted to the General Meeting of Shareholders
Fiscal Period CoveredFiscal year ending March 2025
Items this document does not state (5)
Total dividendsRecord dateEffective dateSource of dividendsBreakdown of Regular, Commemorative and Special Dividends

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

業績が不透明だったため期末配当を未定としていたが、当期の業績見通しを総合的に判断した結果、1株当たり3円とした。配当は安定的に実施し、配当性向50%以上を基本としながら、財務体質の強化や製造設備・技術、研究開発、営業活動への投資にも資金を充当する方針を示している。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Revision of Dividend Forecast | WAKAMOTO PHARMACEUTICAL CO.,LTD. (4512) timely disclosure | Komori